TIGR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. TIGR is in a clear short-term downtrend (bearish MA stack and worsening MACD) and just sold off 3% in the regular session, sitting near support (8.57). Options positioning is bullish-leaning (very low put/call OI), but without any Intellectia buy signals, no near-term news catalysts, and a major sell-rated analyst price target far below the current price, the risk/reward for an impatient entry is unfavorable. I would avoid initiating a new long position today; only reconsider if price reclaims the pivot (~8.91) and starts holding above 9.25.
Trend is bearish: SMA_200 > SMA_20 > SMA_5 indicates persistent downside momentum. MACD histogram is negative (-0.0913) and expanding lower, confirming selling pressure is increasing rather than stabilizing. RSI_6 is ~28, which signals an oversold/washed-out condition and raises the odds of a short bounce, but oversold alone is not a durable entry trigger while MACD and moving averages stay bearish. Price is hovering around key support S1=8.573 (post-market ~8.58); a clean break below opens room toward S2=8.365. Upside levels to regain for a trend shift: pivot 8.909 first, then R1 9.245. Pattern-based forward view provided is weak: expected drift of -0.18% over a week and -4.24% over a month, implying rallies may be sold.
Q3 2025 fundamentals were strong: revenue +73.33% YoY, net income +203.12% YoY, EPS +100% YoY, and gross margin improved to ~84.92%. Oversold RSI near key support can produce a short-term technical bounce if support holds and price recaptures 8.91+. Options open interest is call-heavy (bullish structural tilt).
Technical trend is still down (bearish MA stack + MACD deteriorating), making dips vulnerable to further downside if 8.57 fails (next level ~8.37). No news catalysts in the last week to change narrative or trigger re-rating. Pattern-based outlook provided implies continued weakness into the month (-4.24%).
Latest reported quarter: 2025/Q3. Revenue rose to 175,160,244 (+73.33% YoY). Net income rose to 53,817,668 (+203.12% YoY). EPS increased to 0.02 (+100% YoY). Gross margin improved to ~84.92 (+4.87% YoY). Growth and profitability are clearly improving, but the stock is not currently trading like the market is rewarding that improvement (trend remains bearish).
Recent analyst change: Goldman Sachs (2025-12-05) raised its price target to $4.73 from $4.15 but maintained a Sell rating. Despite acknowledging a Q3 beat, the firm cited slowing client acquisition, weaker HK market conditions, higher US volatility, lower trading velocity, and expected Fed cuts as earnings headwinds. Wall Street pros/cons view from the provided data skews negative: the only cited analyst is explicitly Sell with a target far below the current price (~8.5), implying skepticism about sustainability/quality of earnings and forward activity metrics.
